StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PTGXVery BullishAnalyst Target Updateanalyst
High materiality7/10

Protagonist Therapeutics price target raised to $173 from $118 at Wedbush

Aug 11, 2026, 12:01 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Wedbush raises PTGX target to 173; posted price 149.51; priceChangeSinceSignal 0.33.

  • Target up to $173
  • Price since signal: +0.33

Key facts

  1. 01

    Target: $173

  2. 02

    Posted price: $149.51

  3. 03

    Analyst firm: Wedbush

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.